Seroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali
Microbes & Immunity · 03.04.2026 · 025380102
DOI: 10.36922/mi025380102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbes & Immunity, online erschienen am 03.04.2026. Verfasst von Arama Charles und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) has been associated with the production of autoantibodies and the development of autoimmune disease. However, the prevalence of autoantibodies during the early wave of the pandemic is not known in Mali. We sought to assess the seroprevalence of autoantibodies in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali. A retrospective cross-sectional study was conducted from April to July 2020 at the Charles Mérieux Centre of Infectiology, Bamako. We screened 1,271 individuals suspected of having COVID-19. Samples were tested for SARS-CoV-2 antibodies. Overall, 19% of screened individuals were seropositive for anti–SARS-CoV-2 immunoglobulin G and/or M. Subsequently, ninety serum specimens were selected and analyzed for the detection of autoantibodies using an IDS-iSYS chemiluminescence immunoassay. We found a seroprevalence of 32.22% for autoantibodies. Seroprevalence was similar in women (18.89%) and men (13.33%, p = 0.25). The largest age group in this autoantibody seroprevalence study was 41–60 years (44%). Seroprevalence was higher for antinuclear antibodies and anti-beta-2 glycoprotein IgG, at 20% each. However, it was lower for anti-beta-2 glycoprotein I IgM, anti-cardiolipin IgG, and anti-cardiolipin IgM, and anti-myeloperoxidase antibodies, at 7%. The high seroprevalence of autoantibodies could contribute to the onset or the reactivation of autoimmune disorders during coronavirus infection.
Zitieren
APA
Charles, A., Carlos, G. K., Antoine, D., Tietie, B. A., Tieido, S., Abdramane, G., Karim, S. A., & Bourema, K. (2026). Seroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali. Microbes & Immunity, 0(0), 025380102. https://doi.org/10.36922/mi025380102
Vancouver
Charles A, Carlos GK, Antoine D, Tietie BA, Tieido S, Abdramane G, et al. Seroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali. Microbes & Immunity. 2026;0(0):025380102. doi:10.36922/mi025380102
BibTeX
@article{Charles2026,
author = {Charles, Arama and Carlos, Gaba Komi and Antoine, Dara and Tietie, Bissan Aboubacar and Tieido, Sidibé and Abdramane, Guindo and Karim, Sangaré Abdoul and Bourema, Kouriba},
title = {Seroprevalence of autoantibodies to nuclear and phospholipid antigens in patients infected with SARS-CoV-2 during the first wave of COVID-19 in Mali},
journal = {Microbes & Immunity},
year = {2026},
volume = {0},
number = {0},
pages = {025380102},
doi = {10.36922/mi025380102}
}
EUVIMED